
zzso represents a common finding in cancer patients, especially at an advanced zzso zzso has an impact on the quality of life and at the same time seems to markedly limit the disease control that can be achieved with zzso The results of a series of clinical studies published in the last decade allow some general zzso zzso the administration of erythropoietin, especially if associated to zzso zzso is able to increase zzso levels in cancer patients undergoing radiation therapy zzso with zzso zzso zzso zzso stimulation of zzso in anemia decreases the need for blood zzso in cancer zzso zzso tumor response to radiation therapy appears to be enhanced by zzso zzso zzso Further clinical studies are required for assessment of zzso identification of optimal administration zzso zzso of this promising therapy for patients undergoing radiation zzso 

